483
Kyowa Hakko Bio Co., Ltd.Kyowa Hakko Bio Co., Ltd. – FDA 483, Apr 11, 2022
Record Details
Kyowa Hakko Bio Co., Ltd. in Hofu-city, Japan, an API manufacturer, received a Form 483 with five observations. The inspection revealed significant deficiencies in the quality control unit's adherence to procedures, inadequate evaluation of change control impacts on API quality, insufficient water monitoring specifications, and inadequate laboratory and production system controls. These issues indicate a systemic lack of robust quality management and control.
View Company Profile
ID · 911e3418-d0c9-42ad-a767-662ef0cf7b3d
Other documents for Kyowa Hakko Bio Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.